Keyphrases
Hepatocytes
100%
Nonalcoholic Steatohepatitis
100%
Nanotechniques
100%
Extracellular Vesicles
100%
Liver Disease
100%
Obesity
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
34%
Steatosis
25%
Liver Biopsy
20%
Liver
14%
Nanoplasmonics
11%
Normal Liver
8%
Bariatric Surgery
8%
Longitudinal Follow-up
8%
Inflammation
8%
Fibrosis
8%
Mayo Clinic
8%
Chronic Liver Disease
5%
Nanorods
5%
CD63
5%
Direct Medical Costs
5%
AlInAs
5%
Hepatocellular Injury
5%
Vesicle Protein
5%
Assay Platform
5%
Disease-related
5%
Early Diagnosis
5%
United States
5%
Adverse Events
5%
Plasma Samples
5%
Cirrhosis
5%
Biomarker Testing
5%
Strong Potential
5%
Arizona State University
5%
High-risk Population
5%
Biochemistry, Genetics and Molecular Biology
Hepatocyte
100%
Blood Plasma
91%
Lipid
16%
Population Risk
16%
Ultracentrifugation
16%
CD63
16%
Nucleic Acid
8%
Magnetism
8%
CD9
8%
Proteome
8%
Screening Test
8%
High Throughput Screening
8%
Isolated Liver
8%
Western Blot
8%
Antibodies
8%
TSG101
8%
Life Expectancy
8%
Chromatin Immunoprecipitation
8%
Hydrolase
8%
Clinical Research
8%
Transmembrane Protein
8%
Membrane Protein
8%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Biological Marker
100%
Liver Disease
100%
Steatosis
18%
Diseases
12%
Liver Cell Damage
6%
Fibrosis
6%
Inflammation
6%